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Objectives: Hemispheric neurologic symptoms, amaurosis fugax, and Hollenhorst plaques at eye examination are standard
indications for carotid imaging to identify carotid artery occlusive disease (CAOD). Previous reports have suggested that
other ocular findings, such as retinal artery occlusion and anterior ischemic optic neuropathy, are associated with CAOD.
However, the predictive value of ocular findings for the presence of CAOD is controversial. The purpose of this study was
to define the predictive value of ocular symptoms and ophthalmologic examination in identifying significant CAOD.
Methods: Over 3 years 145 patients were referred for carotid imaging on the basis of ocular indications in 160 eyes. Forty
patients were excluded because of concurrent non-ocular indications for carotid imaging, leaving 105 patients referred
exclusively for ocular indications to evaluate. Ophthalmologic history and eye examination were correlated with carotid
duplex ultrasound findings.
Results: Amaurosis fugax was associated with a positive scan in 20.0% of carotid arteries (P .022). Hollenhorst plaques
at fundoscopic examination were associated with a positive scan in 18.2% of carotid arteries (P  .02). Ocular findings
exclusive of Hollenhorst plaques were particularly poor predictors of CAOD, inasmuch as only 1 of 64 arteries (1.6%) had
significant ipsilateral internal carotid artery stenosis (P  .022). Venous stasis retinopathy was the only ocular finding
other than Hollenhorst plaques with any predictive value (1 of 5 scans positive; positive predictive value, 20.0%).
Conclusions: Ocular symptoms and findings are poor predictors of CAOD. Amaurosis fugax, Hollenhorst plaques, and
venous stasis retinopathy demonstrated moderate predictive value, whereas all other ocular findings demonstrated no
predictive value in identifying CAOD. (J Vasc Surg 2004;40:279-86.)A history of transient monocular blindness, such as
amaurosis fugax, and visualization of cholesterol (Hollen-
horst) plaques at fundoscopic examination are accepted
indications for diagnostic testing to identify carotid artery
occlusive disease (CAOD).1-3 Previous reports have sug-
gested that other ocular findings, such as retinal emboli,
neovascularization of the iris or retina, ischemic optic neu-
ropathy, venous stasis retinopathy, and ocular ischemic
syndrome, are associated with carotid disease.4-7 However,
the predictive value of these findings for the presence of
CAOD is not well defined. The reported incidence of
CAOD among patients with ocular findings varies dramat-
ically, ranging from 0% to 100%.8 The present study sought
to define the predictive value of ocular symptoms and
fundoscopic findings for identifying significant CAOD.
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Study population. Over 3 years, from September
2000 to July 2003, 2799 patients were examined with
duplex ultrasound scanning for carotid artery stenosis at the
clinical vascular laboratory of the Dallas Veterans Affairs
Medical Center. Of patients referred for evaluation of the
carotid arteries, 145 patients were referred because of ocu-
lar signs or symptoms. Forty patients were excluded be-
cause of a concurrent history of hemispheric neurologic
symptoms, known carotid stenosis, or a carotid bruit that
warranted carotid imaging independent of the ocular find-
ings. The remaining 105 patients were referred exclusively
on the basis of ocular signs or symptoms in 116 eyes. This
cohort constituted the study population for this report.
Ninety-five of the 105 patients were referred by ophthal-
mologists, and 10 patients with symptoms of amaurosis
fugax were referred by primary care specialists.
Ophthalmologic examination. Eye examinations
were performed for routine follow-up or were prompted by
acute or chronic visual complaints. All eye examinations
consisted of visual acuity, pupil testing, intraocular pres-
sure, dilated fundus examination, and visual field testing if
indicated. Ophthalmologic diagnoses were based on stan-
dard diagnostic criteria, and were reviewed for accuracy by
a supervising attending ophthalmologist (C.G.R.). The
distinction between amaurosis fugax and transient visual
obscuration was subjective and based primarily on duration
of monocular vision loss. The vision loss of transient visual279
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fugax persisted for longer than 1 minute.9 Inasmuch as
symptoms of transient visual obscuration may be associated
with anterior ischemic optic neuropathy, which has been
associated with CAOD in previous studies,9 this clinical
diagnosis was analyzed separately from amaurosis fugax.
Carotid artery duplex imaging. The extracranial ca-
rotid arteries were assessed with duplex ultrasound scan-
ning in an Intersocietal Commission for Accreditation of
Vascular Laboratories–accredited vascular laboratory at the
Dallas Veterans Affairs Medical Center, with either an ATL
HDI 3000 (Philips Medical Systems) or Acuson 128XP10
(Siemens Medical Systems) ultrasound system. Carotid ar-
teries were interrogated with a 5-MHz linear probe. The
maximal stenosis of the internal carotid artery (ICA) was
determined with Doppler-derived velocities and B-mode
imaging. Velocity criteria were modified from Moneta et
al10 after internal validation with cerebral arteriography.
One patient underwent arteriography rather than duplex
ultrasound scanning to image the carotid artery. Five pa-
tients with amaurosis fugax had intermediate (40%-59%)
stenosis at duplex ultrasound scanning, and subsequently
underwent arteriography to more precisely define the ste-
nosis for therapeutic decision-making.
The results of imaging of the ipsilateral carotid artery
were correlated with ocular symptoms and findings at oph-
thalmologic examination. To facilitate statistical analysis, a
positive carotid ultrasound finding was defined as stenosis
of 50% or greater loss of luminal diameter in patients with
amaurosis fugax, based on criteria established by the North
America Symptomatic Carotid Endarterectomy Trial
(NASCET).11 In patients with other ocular symptoms or
examination findings a positive carotid ultrasound finding
was defined as stenosis of 60% or greater. This definition is
based on the minimum stenosis considered for carotid
endarterectomy (CEA) in patients with asymptomatic dis-
ease at our institution, based on criteria established by the
Asymptomatic Carotid Atherosclerosis Study (ACAS).12
ACAS criteria were applied because we deemed patients
with fundoscopic abnormalities alone as “asymptomatic” in
the absence of hemispheric neurologic symptoms or amau-
rosis fugax.
Statistical analysis. Continuous data were expressed
as mean SEM. Continuous data were compared between
groups with one-way analysis of variance. The association
between ocular findings and carotid disease was assessed
with 2 analysis or the Fisher exact test where appropriate.
Probabilities for specificity, sensitivity, and positive predic-
tive value of nonparametric data were expressed as proba-
bility percentage (95% confidence interval). For all statisti-
cal analyses the threshold for significance was P  .05.
Statistical analysis was performed with Statistical Package
for the Social Sciences software (version 11.5 for Windows;
SPSS, Inc).
RESULTS
The study population consisted of 101 (96.2%) men
and 4 (3.8%) women, with mean age 66.7  0.8 years(range, 42-86 years). The indications for evaluation are
listed in Table I. The most common indications for carotid
imaging were symptoms of amaurosis fugax (n  30 arter-
ies) or fundoscopic findings of Hollenhorst plaques (n 22
arteries). A subset of carotid arteries was imaged because of
the presence of other ocular findings (n  64 arteries)
purported to be associated with CAOD (Table I). Patient
demographic data, stratified by indication for carotid imag-
ing, are outlined in Table II. There were no significant
differences in age or distribution of gender or risk factors
between groups of patients referred with amaurosis fugax,
Hollenhorst plaques, or other ocular indications (Table II).
The results of carotid duplex scanning for ocular indi-
cations are outlined in Table III. Carotid imaging results
were stratified by ocular indication, and separated into
categories of stenosis determined at duplex ultrasound
scanning (Table III). A minority of patients with amaurosis
fugax (n 5) had stenosis in the 40% to 59% category, and
underwent arteriography to more accurately characterize
the degree of stenosis for clinical decision making. The rate
of positive scans for each indication is outlined in Table IV.
Eleven of 116 arteries (9.5%) referred because of ocular
indications alone demonstrated positive findings on carotid
scans (Table IV). Symptoms of amaurosis fugax were most
predictive of carotid stenosis (50% stenosis); 6 of 30
arteries (20.0%) had a carotid stenosis of 50% or greater in
the ipsilateral carotid artery. When the threshold for a
positive scan for amaurosis fugax was increased to stenosis
of 60% or greater in the ipsilateral carotid artery, the rate of
positive scans was 10% (3 of 30 arteries) for amaurosis
fugax. There was no difference in the rate of positive carotid
scans for patients referred with amaurosis fugax by ophthal-
mologists versus other clinicians.
Among 30 patients with amaurosis fugax, single epi-
sodes of monocular vision loss were documented in 18 and
multiple episodes were documented in 12. Stratifying pa-
tients on the basis of number of episodes of amaurosis fugax
proved to be instructive. Five of 12 patients (41.7%) with
multiple episodes of amaurosis fugax had positive findings
on carotid scans (50% stenosis), compared with only 1 of
18 patients (5.6%) with a single episode of amaurosis fugax.
Among 24 patients with amaurosis fugax and a carotid
stenosis less than 50%, additional workup to identify an
Table I. Indications for carotid ultrasound scanning
Symptoms at presentation No. of eyes %
Amaurosis fugax 30 25.9
Hollenhorst plaques 22 19.0
Other ocular findings 64 55.2
Anterior ischemic optic neuropathy 15 12.9
Transient visual obscuration 12 10.3
Retinal artery occlusion 11 9.5
Optic atrophy 9 7.8
Asymmetric diabetic retinopathy 7 6.0
Venous stasis retinopathy 5 4.3
Ocular ischemic syndrome 3 2.6
Retinal vein occlusion 2 1.7
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phy in 9 patients. Only 1 of 9 echocardiograms identified a
cardiac thrombus.
The finding of Hollenhorst plaques at eye examination
was associated with a positive carotid scan (60% stenosis)
in 4 of 22 arteries (18.2%). Other ocular findings were
generally poor predictors of ipsilateral carotid stenosis; only
1 of 64 arteries (1.6%) had significant (60%) ipsilateral
stenosis. With the exception of Hollenhorst plaques, ve-
nous stasis retinopathy proved to be the only fundoscopic
Table II. Patient demographic data stratified by indication
Demographic data Amaurosis fugax H
Mean age (y) 66.9  0.6
Gender (% male) 92
Hypertension (%) 77
Hyperlipidemia (%) 36
Diabetes mellitus (%) 64
Heart disease (%) 50
Tobacco use (%) 72
*Includes anterior ischemic optic neuropathy, transient visual obscuration,
stasis retinopathy, ocular ischemic syndrome, and retinal vein occlusion.
Table III. Results of carotid scanning by indication
Indication for scanning Normal 1%–3
Amaurosis fugax 17 5
Hollenhorst plaques 9 8
Other ocular findings 45 15
Anterior ischemic optic neuropathy 12 2
Transient visual obscuration 10 1
Retinal artery occlusion 4 6
Optic atrophy 7 2
Asymmetric diabetic retinopathy 4 3
Venous stasis retinopathy 3 1
Ocular ischemic syndrome 3 0
Retinal vein occlusion 2 0
*Table includes number of scans corresponding to each category of stenosi
Table IV. Frequency of positive scans ( 60% stenosis) by
Anterior ischemic optic neuropathy n
Hollenhorst plaques 4
Other ocular findings 1
Anterior ischemic optic neuropathy 0
Transient visual obscuration 0
Retinal artery occlusion 0
Optic atrophy 0
Asymmetric diabetic retinopathy 0
Venous stasis retinopathy 1
Ocular ischemic syndrome 0
Retinal vein occlusion 0
*Percentage of positive scans (60% stenosis) based on total number of scafinding associated with CAOD, with 1 of 5 scans (20.0%)
demonstrating stenosis of 60% or greater. All other oph-
thalmologic symptoms and examination findings, includ-
ing anterior ischemic optic neuropathy, retinal artery occlu-
sion, optic atrophy, asymmetric diabetic retinopathy,
ocular ischemic syndrome, transient visual obscuration, and
retinal vein occlusion, failed to uncover any carotid stenosis
of 60% or greater.
The rate of positive carotid scans in patients referred
with ocular symptoms or fundoscopic findings as the only
carotid imaging
ation for scanning
Phorst plaques Other ocular finding*
.5  0.7 67.4  0.9 .372
96 98 .498
82 75 .791
41 35 .856
59 53 .522
41 40 .756
78 70 .852
l artery occlusion, optic atrophy, asymmetric diabetic retinopathy, venous
Stenosis*
40%–59% 60%–79% 80%–99% Occluded
5 2 1 0
1 2 1 1
3 0 1 0
1 0 0 0
1 0 0 0
1 0 0 0
0 0 0 0
0 0 0 0
0 0 1 0
0 0 0 0
0 0 0 0
rmined at duplex ultrasound scanning.
lar finding
Positive scans*
Total scans%
18.2 22
1.6 64
0 15
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0 11
0 9
0 7
20.0 5
0 3
0 2
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comparison, the prevalence of significant carotid disease
(60% stenosis) among all patients (n 2799) undergoing
carotid duplex ultrasound scanning at the same institution
during the study period was 17.0%. Among the 40 patients
with ocular findings who were excluded from statistical
analysis because of the presence of a concurrent indication
for carotid imaging, such as hemispheric neurologic symp-
toms, previous CEA, known carotid stenosis, or carotid
bruit, 14 of 42 arteries (33.3%) had significant CAOD
(60% stenosis; Table V). The rate of positive carotid scans
for the various combinations of ocular symptoms or find-
ings with other potential markers of CAOD are shown in
Table V. In the presence of another marker for CAOD, a
history of amaurosis fugax yielded a positive carotid scan in
13 of 22 arteries (59.1%). This represents a higher yield of
positive carotid scans than we noted for amaurosis fugax in
the absence of a concurrent marker for CAOD (20.0%).
However, the presence of a concurrent marker for CAOD
did not increase the rate of positive carotid scans in patients
with with Hollenhorst plaque or other ocular examination
Table V. Frequency of positive scans for ocular indication
Indication for scanning
Amaurosis fugax  hemispheric symptoms
Amaurosis fugax  CAOD
Amaurosis fugax  bruit
Hollenhorst plaques  hemispheric symptoms
Hollenhorst plaques  CAOD
Other ocular findings  hemispheric symptoms, CAOD, or bruit
AION  hemispheric symptoms
AION  CAOD
Transient visual obscuration  bruit
Retinal artery occlusion  hemispheric symptoms
Retinal artery occlusion  CAOD
Retinal artery occlusion  bruit
Asymmetric diabetic retinopathy  hemispheric symptoms
Venous stasis retinopathy  hemispheric symptoms
Venous stasis retinopathy  bruit
Ocular ischemic syndrome  hemispheric symptoms
CAOD, Known carotid artery occlusive disease or previous carotid endarter
*Percentage of positive scans based on total number of scans obtained for tha
for all other ocular indications (see Methods).
Table VI. Diagnostic efficacy of ocular symptoms and find
Indication
Sensitivity Specifi
% 95% CI % 9
Amaurosis fugax 54.6 25.1-84.0 77.1 69
Multiple episodes 83.3 53.5-100.0 70.8 52
Hollenhorst plaques 50.0 17.4-82.6 83.3 74
Other ocular findings 12.5 0.7-53.3 41.7 32
Venous stasis 12.5 0.7-53.3 96.3 90
PPV, Positive predictive value; CI, confidence interval.
*Positive scan for amaurosis fugax is 50% stenosis, and 60% stenosis for
†Fisher exact test.findings (Table V). Within the subset of patients with a
concurrent marker for CAOD, venous stasis retinopathy
proved to be the only fundoscopic finding associated with a
positive carotid scan, with 1 of 3 scans (33.3%) demonstrat-
ing stenosis of 60% or greater (Table V).
The utility of ocular symptoms and ophthalmologic
findings in identifying patients with carotid stenosis was
assessed further by determining the sensitivity, specificity,
positive predictive value, and likelihood ratio of each ocular
finding (Table VI), excluding patients with another poten-
tial marker for CAOD. Sensitivity for ocular symptoms and
findings in the identification of CAOD was generally low
(range, 12.5%-83.3%). Of the parameters examined, amau-
rosis fugax was the most sensitive for detecting significant
CAOD (stenosis 50%), with sensitivity of 54.6%. The
sensitivity of amaurosis fugax for detecting CAOD (50%
stenosis) was increased by the presence of multiple episodes
of amaurosis fugax (sensitivity, 83.3%) compared with a
single episode of amaurosis fugax (sensitivity, 16.7%). Hol-
lenhorst plaques were slightly less sensitive (50.0%) in
enabling detection of significant CAOD, which was defined
concurrent marker of CAOD
Positive scans*
Total scansn %
2 50 4
4 80 5
7 53.8 13
0 0 5
0 0 2
1 7.7 13
0 0 3
0 0 1
0 0 1
0 0 1
0 0 1
0 0 1
0 0 1
0 0 2
1 100 1
0 0 1
y; AION, anterior ischemic optic neuropathy.
ation. Positive scan for amaurosis fugax is50% stenosis, and60% stenosis
*
PPV
Likelihood
ratio 2 PI % 95% CI
5.2 20.0 5.7-34.3 4.571 5.22 .022
9.0 41.7 13.8-69.6 5.999 .026†
9.6 18.2 6.0-41.0 3.000 5.39 .020
1.6 1.6 0.0-9.5 0.214 .022†
8.8 20.0 1.1-70.1 3.375 .305†
er ocular indications (see Methods).s with
ectom
t indicings
city
5% C
.1-8
.6-8
.7-8
.4-5
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The sensitivity of ocular conditions other than amaurosis
fugax or Hollenhorst plaques for detecting significant
CAOD was particularly dismal (12.5%). Among these other
findings, only venous stasis retinopathy provided a positive
carotid scan in 1 of 5 arteries examined, yielding a sensitiv-
ity of 12.5%. The remaining 63 arteries examined because
of other ocular symptoms or examination findings had no
significant (60%) carotid stenosis. Consequently, the pos-
itive predictive value for ocular findings other than amau-
rosis fugax and Hollenhorst plaques was 1.6%. Within this
subset of patients, only venous stasis retinopathy had any
predictive value for identifying carotid stenosis of 60% or
greater (positive predictive value, 20.0%). The likelihood
ratios of amaurosis fugax, Hollenhorst plaques, and venous
stasis retinopathy were 4.571, 3.000, and 3.375, respec-
tively (Table VI), indicating that the presence of any of
these findings increased the likelihood of CAOD (60%
stenosis) by at least threefold. The likelihood ratio for all
other ocular symptoms and examination findings was
0.214 (Table VI; P  .022), indicating that there is no
positive association between these ocular findings and
CAOD.
Six patients with amaurosis fugax and carotid stenosis
exceeding 50% luminal narrowing at duplex ultrasound
scanning or cerebral arteriography underwent CEA (n 5)
or stenting (n  1), on the basis of established criteria for
symptomatic disease.11 Two patients with amaurosis fugax
and intermediate (40%-59%) stenosis underwent cerebral
arteriography, which revealed stenosis less than 50%, and
were given anti-platelet therapy. Four patients with asymp-
tomatic Hollenhorst plaques and carotid stenoses 60% or
greater were treated medically owing to patient preference
(n  2), comorbid medical conditions (n  1), or an
occluded ICA (n  1). One patient with venous stasis
retinopathy and critical (80%-99%) ICA stenosis was
treated with anti-platelet therapy because of chronic pan-
creatitis, and died 2 months later.
DISCUSSION
The present study found that the predictive value of
fundoscopic findings for identifying CAOD is variable, but
generally poor. The presence of amaurosis fugax, Hollen-
horst plaques, or venous stasis retinopathy was associated
with significant carotid artery disease in approximately 1 in
5 arteries examined. Other eye symptoms and fundoscopic
findings, including transient visual obscuration, anterior
ischemic optic neuropathy, retinal artery occlusion, optic
atrophy, asymmetric diabetic retinopathy, ocular ischemic
syndrome, and retinal vein occlusion, were not associated
with significant CAOD in 63 arteries referred exclusively on
the basis of these ocular findings.
The present study differs from previous studies in its
methodologic approach to defining the predictive value of
ocular symptoms and examination for identifying CAOD.
First, all patients with other potential indications for carotid
imaging were excluded from the study. Exclusion criteria
included hemispheric neurologic symptoms, carotid bruits,or known carotid stenosis. These patient factors usually
merit carotid imaging regardless of ocular symptoms or
examination findings. More important, however, these fac-
tors are associated with CAOD. By excluding these poten-
tial markers for CAOD we were able to minimize bias in our
assessment of the association between ocular symptoms and
examination findings and CAOD. Patients with amaurosis
fugax and one of these exclusion criteria had a 59.1%
incidence of significant CAOD (Table V), which is signifi-
cantly higher than the 20.0% rate of positive scans observed
in the study cohort, and underscores the potential bias of
including patients with these concurrent markers for
CAOD. Of note, inclusion of patients with other markers
for CAOD did not increase the rate of positive scans in
patients with ocular indications other than amaurosis fugax
(Table V).
Although amaurosis fugax and Hollenhorst plaques are
accepted indications for carotid duplex ultrasound scan-
ning, their association with CAOD in previous reports has
been highly variable, ranging from 14% to 83%. Kirshner et
al13 reported an 83% incidence of carotid stenosis (75%)
in patients with amaurosis fugax, but that study was limited
to patients who underwent CEA and excluded patients
without significant carotid stenosis. Such a study design
precluded determination of actual prevalence of carotid
stenosis among patients with amaurosis fugax. Using a
study design similar to the present study, Chawluk et al14
reported a 14% incidence of carotid stenosis (60%) in
patients with amaurosis fugax, which is comparable to the
20% incidence noted in the present study. In contrast, Bull
et al15 reported an incidence of significant (60%) carotid
stenosis of 53% in patients with amaurosis fugax, using a
study design similar to the present study but without ex-
clusion of patients with other potential markers for CAOD.
When we examined patients with amaurosis fugax and a
concurrent marker for CAOD, the rate of positive scans
increased to 59.1%, which is remarkably similar to the
results reported by Bull et al.15 In the present study,
Hollenhorst plaques at fundoscopic examination were as-
sociated with significant (60%) carotid stenosis in 18.2%
of patients, which is comparable to previous reports.4,8
A principal focus of the present study was determina-
tion of the predictive value of fundoscopic findings other
than Hollenhorst plaques for identifying CAOD. The re-
ported utility of these ocular findings in identifying carotid
disease is controversial.8,16,17 Previous reports have sug-
gested that venous stasis retinopathy is associated with
CAOD in 27% to 100% of cases.7,18 A series of 32 patients
with venous stasis retinopathy concluded that 29% of pa-
tients with venous stasis retinopathy had significant (70%)
carotid stenosis.18 However, that study was limited to
patients with known CAOD and excluded patients without
carotid stenosis. Such a study design precludes any assess-
ment of the true prevalence of CAOD in patients with
venous stasis retinopathy. In a review article, Carter7 culled
30 patients with venous stasis retinopathy from 16 pub-
lished studies, and concluded that 90% of patients with
venous stasis retinopathy have carotid occlusive disease.
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nosis, and patients with other indications for carotid imag-
ing, such as amaurosis fugax or hemispheric neurologic
symptoms, were included in Carter’s study.7 Using a study
design similar to the present study, Bull et al15 reported a
100% association between venous stasis retinopathy and
carotid disease (60% stenosis) in 2 patients, whereas the
present study noted significant carotid disease in 1 of 5
patients (20.0%) with venous stasis retinopathy. On the
basis of its larger study population, the current report
appears to be a more accurate assessment of the prevalence
of carotid stenosis in patients with venous stasis retinopa-
thy.
Excluding Hollenhorst plaques and venous stasis reti-
nopathy, the present study found that no other fundo-
scopic findings were associated with significant carotid dis-
ease (60% stenosis) in 63 carotid arteries examined
(Tables III and IV). By comparison, the reported preva-
lence of CAOD in patients with anterior chamber ischemic
optic neuropathy ranges from 0% to 100%.6,13,17 Kirshner
et al13 noted that all 8 of their patients with anterior
ischemic optic neuropathy had carotid occlusive disease,
but that study was biased by limiting the study population
to patients who underwent CEA. In contrast, reports by
Muller et al6 and Fry et al17 noted no significant carotid
stenosis (50%) in 30 patients with anterior ischemic optic
neuropathy. Our findings appear to corroborate previous
studies of the lack of association between anterior ischemic
optic neuropathy and carotid stenosis.6,17
The reported prevalence of CAOD associated with
retinal artery occlusions is also highly variable, ranging from
0% to 24%.14-16 Studies by Chawluk et al14 and Sharma et
al16 reported an incidence of CAOD (60% stenosis) of
24% and 22.4%, respectively, in patients with retinal artery
occlusions. Wakefield et al19 found that 11% of their pa-
tients with retinal artery occlusions had significant CAOD
(60% stenosis). Using a study design similar to the
present study, Bull et al15 found no association between
branch or central retinal artery occlusions and CAOD
(60% stenosis) in 7 patients, which supports the findings
of the present study. The most optimistic of these reports
suggests that retinal artery occlusion has a sensitivity of 39%
in detecting significant carotid disease, making it a poor
predictor of CAOD (60% stenosis).16 Our findings sug-
gest no association between retinal artery occlusions and
CAOD (60% stenosis) in 11 patients (Table IV).
The results of the present study question the utility of
many ocular findings for detecting carotid disease. It has
become standard practice for many clinicians to pursue
imaging of the extracranial carotid arteries when certain
ocular symptoms or fundoscopic findings are noted. Our
results suggest that many of these ocular indications are
poor predictors of CAOD. The relatively higher prevalence
of carotid disease in patients with amaurosis fugax or Hol-
lenhorst plaques may support the continued referral of
these patients for carotid scanning. Nearly one third of
patients with amaurosis fugax had intermediate stenosis
(Table III) that would warrant either operative interven-tion, if the stenosis exceeded 50% luminal narrowing,11 or
anti-platelet therapy and surveillance for potential progres-
sion. However, the overall paucity of predictive value of
other ocular indicators is questionable. Although identifi-
cation of a significant (60%) carotid stenosis was rare (1 of
64 arteries) in patients with ocular findings other than
amaurosis fugax and Hollenhorst plaques, it may be argued
that intermediate stenosis (40%-59%) is also an important
clinical finding if medical therapy or sonographic surveil-
lance is altered by this finding. Intermediate carotid steno-
ses also proved rare in patients with ocular findings other
than amaurosis fugax or Hollenhorst plaques; only 3 of 64
arteries (4.6%) had 40% to 59% carotid stenosis.
There are inherent limitations to the present study. The
present series represents a retrospective review of the expe-
rience at a single institution. Moreover, ocular symptoms
such as amaurosis fugax and transient visual obscurations
are inherently subjective diagnoses based on patient de-
scription and clinician interpretation of the symptoms. As
such, the data derived from this study reflect the prevalence
of CAOD in patients referred by clinicians at our institu-
tion, and may not reflect the prevalence of CAOD at other
institutions where the threshold for referral or patient pop-
ulation may be different. A further concern relates to the
number of patients in each diagnostic category, which
could undermine the statistical power of the study in assess-
ing the predictive value of ocular findings. This problem is
a consequence of the relative infrequency of many of these
ocular symptoms and examination findings. The paucity of
patients within each diagnostic category may have particu-
lar bearing on the interpretation of our findings related to
venous stasis retinopathy. Because there were only 5 pa-
tients with venous stasis retinopathy, any possible associa-
tion between this ocular finding and CAOD should be
interpreted with considerable caution.
In conclusion, ocular symptoms and findings at fundo-
scopic examination are generally poor predictors of signif-
icant carotid disease. Amaurosis fugax, Hollenhorst
plaques, and venous stasis retinopathy have the highest
predictive value among ocular conditions, and warrant
referral for carotid imaging. Transient visual obscurations
may be difficult to differentiate from amaurosis fugax by
clinical history; therefore screening of patients with this
condition is also warranted. However, our data suggest that
fundoscopic findings of anterior ischemic optic neuropa-
thy, retinal artery occlusion, optic atrophy, asymmetric
diabetic retinopathy, ocular ischemic syndrome, or retinal
vein occlusion do not appear to be associated with ad-
vanced CAOD in the absence of other signs or symptoms of
carotid disease.
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Available online Jun 25, 2004.DISCUSSIONDr F. Noel Parent III (Norfolk, Va). This paper achieves its
stated goal by defining the predictive value of ocular symptoms and
fundoscopic findings for identifying significant carotid artery oc-
clusive disease. We have heard how 116 abnormal eye symptoms or
findings led to a carotid duplex ultrasound. A positive study was
equivalent to a potentially operative lesion. The question is not
whether the carotid duplex ultrasound identifies disease in patients
with eye symptoms or findings, but whether eye symptoms or
findings are associated with a positive carotid duplex ultrasound
study. It appears that more than a few patients with eye symptoms
or findings are referred for a carotid duplex ultrasound that is
negative for operative disease. Without restating the data, the
statistical analysis is appropriate and the facts support the conclu-
sions that, to paraphrase, maybe the ophthalmologists should not
send patients for a carotid duplex ultrasound every time they see
something abnormal in the eye, because of a low carotid surgical
harvest. My commentary draws attention to the patients with the
lesser positive carotid duplex ultrasound findings. Mild plaque in
the carotid artery may not be a harbinger of future stroke, but it is
a manifestation of systemic atherosclerosis. Vascular surgeons have
a vital role to play here. The opportunity to address risk factors, to
arrange future follow-up carotid duplex ultrasound examinations
and to examine the patient for abdominal aortic aneurysm and
peripheral, renal, or mesenteric atherosclerosis is a service that we
should provide and not overlook. In our area the cardiologists and
other interventionists are glad to do it; it is a finders-keepers game.
If Table II is reanalyzed by looking at all carotid duplex ultra-
sounds that are “not normal,” then the rate of “positive” studies
jumps from 6.9% to 39%. The 2 and other statistics for significance
in Table IV all stay the same, except for the category of “other
vascular findings,” where now the likelihood ratio is 1.47. Al-
though I am sure there is a practical need to minimize the rate of
normal studies in a busy VA vascular lab, where resources may be
limited, I have three questions: (1) Please tell us if you plan to
discuss with your referring ophthalmologists to not send patients
with some of these other ocular findings for a carotid duplex
ultrasound? (2) Could you educate us about what venous stasis
retinopathy is? In a word association game with my ophthalmolo-
gist, the first diagnosis she thought of when I said “venous stasisretinopathy” was “hypertension.” What does this have to do with
carotid disease? And (3), Was any carotid disease in the contralat-
eral eye carotid pair found, and how did you handle these data?
Dr J. Gregory Modrall. First of all, we have not asked our
referring ophthalmologists to cease referring patients. However,
we have attempted to educate them on the likelihood of a positive
test, noting that the association between ocular findings and
carotid disease is extremely weak. In the VA population, which may
be different from your practice environment, we counsel the
patient on the potential remedies to any carotid stenosis, including
surgery. Many of those patients decline operative intervention. In
those patients the carotid scan is being used to guide medical
therapy and to decide if a follow-up carotid ultrasound is indicated.
Regarding your question about the definition of venous stasis
retinopathy, this diagnoses is made at funduscopic examination. It
is somewhat subjective, but there are specific diagnostic criteria,
including flame hemorrhages and other such funduscopic charac-
teristics. In the ophthalmologic textbooks there is a long list of
potential associations with venous stasis retinopathy, including
hypertension, as you noted. However, carotid disease is promi-
nently mentioned on those lists. When one peruses the literature
the reported association of venous stasis retinopathy with carotid
disease is extremely variable, ranging from 0% to 100%, depending
on the size of the series. Unfortunately, that diagnosis is so rare
that a recent meta-analysis required 16 different studies to compile
30 patients. As such, any conclusions regarding venous stasis
retinopathy as a predictor of carotid disease will be hindered by the
infrequency of that diagnosis.
Regarding your question about patients with less than 60%
stenosis, I think it is prudent to distinguish patients with stenosis of
40% to 59% versus those with stenosis of 5% to 10%, as the latter
group is unusual in a VA population. If we were to include all
patients with stenosis of less than 40%, then these statistics would
be altered in the manner that you suggested. If we include any
stenoses exceeding 40%, there is virtually no change in the statis-
tical analysis we presented. In fact, the rate of positive scans for
ocular findings other than Hollenhorst plaques and amaurosis
fugax is increased from 1.6% to 5.6%, which is not a significant
clinical difference, in our opinion.
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August 2004286 McCullough et alDr Bruce Perler (Baltimore, Md). This is a very intriguing
presentation, and maybe for me somewhat disillusioning. I think
all of us recognize that amaurosis has always been viewed as a classic
sign of carotid occlusive disease and an accepted indication for
endarterectomy. As I understand your data, what you are telling us
is that amaurosis is an exceedingly insensitive predictor of carotid
disease, which I think in my mind raises a couple of questions.
Should we in fact be liberalizing the indications for endarterectomy
in patients with amaurosis to less than 60% or 50% stenosis? Are
there many patients out there with hemodynamically insignificant
but clinically significant stenosis? Could you give us some informa-
tion on the suspected cause of the transient visual loss in patients in
whom you could not confirm carotid bifurcation disease?
Dr Modrall. It is very clear that the association that has
been reported in the literature is highly variable, but our resultsare within the range of the reported literature. When you look
carefully at the studies that show a higher degree of association
between amaurosis and carotid disease, often there are serious
methodologic issues, such as restricting the patient population
to patients who have undergone carotid endarterectomy, to
define an association between amaurosis and carotid disease. It
is obvious that such a study design would bias the association
significantly.
In terms of patient selection for carotid endarterectomy, we
adhere rigorously to the NASCET criteria, so I cannot condone
liberalizing one’s indications for surgery based on our data. It is
clear, however, that not every patient with amaurosis will have
carotid disease. In fact, these data appear to confirm that there
are numerous other sources for amaurosis, such as the aortic
arch.The JVS Ombudsman
The ombudsman’s role is to act as an advocate for authors and represent their position to the editorial staff in
relation to the process of manuscript submission, review, and publication. The ombudsman is not responsible for
evaluating the content of a manuscript or determining whether the editors made the correct decision with regard to
acceptance or rejection of the paper. If an author or other person has an unresolved complaint or question about the
editorial process of the Journal, he or she should contact Dr James S. T. Yao (Northwestern University Medical
School, Department of Surgery, 201 E. Huron Street, Suite 10-105, Chicago, IL 60611), who will review the matter.
